Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:55 PM
Ignite Modification Date:
2025-12-24 @ 2:55 PM
NCT ID:
NCT00906659
Eligibility Criteria:
Inclusion Criteria:
* type 2 diabetes
* regardless of diabetes duration and retinopathy severity level
* one or both eyes with focal clinically significant macular edema
* treated with selective or focal photocoagulation
* visual capacity under subjective refraction before and three weeks after treatment
* adequate quality 6 mm fast macular map both on the day of photocoagulation, and three weeks after it
Exclusion Criteria:
* patients with myopia over -6.00 diopters
* any retinal disease different from diabetic retinopathy at the moment of photocoagulation
* eyes with a thickened posterior vitreous
* eyes with vitreoretinal traction at the macula
* if they had required scatter photocoagulation before the three weeks evaluation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
70 Years
Study:
NCT00906659
Study Brief:
Protocol Section:
NCT00906659